[HTML][HTML] Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of …
M Khan, J Lin, G Liao, Y Tian, Y Liang, R Li, M Liu… - Medicine, 2018 - journals.lww.com
Background: Recently, immune checkpoint inhibitors have shown survival advantage over
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized …
M Khan, J Lin, G Liao, Y Tian, Y Liang, R Li, M Liu… - Medicine, 2018 - europepmc.org
Background Recently, immune checkpoint inhibitors have shown survival advantage over
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
[引用][C] Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer
M Khan, J Lin, G Liao, Y Tian, Y Liang, R Li, M Liu… - Medicine, 2018 - cir.nii.ac.jp
Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of
advanced non-small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
advanced non-small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized …
M Khan, J Lin, G Liao, Y Tian, Y Liang, R Li… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Recently, immune checkpoint inhibitors have shown survival advantage over
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
[HTML][HTML] Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of …
M Khan, J Lin, G Liao, Y Tian, Y Liang, R Li, M Liu… - Medicine, 2018 - ncbi.nlm.nih.gov
Background: Recently, immune checkpoint inhibitors have shown survival advantage over
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …
chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta …